Indaptus Therapeutics INDP Cash Flow Statement (2020-2026)

NASDAQ INDP
$2.85 -0.44 (-13.37%)
At close: Sep 29, 2026 · 4:00 PM EDT
Reported Financials

Indaptus Therapeutics Quarterly Cash Flow Statement

Periods 26 quarters
Latest Jun 2026

Indaptus Therapeutics reported cash from operations of -$1.93M and free cash flow of -$1.93M for the quarter ended Jun 2026, up 52.0% year over year. This cash flow statement covers 26 quarters of results from Mar 2020 through Jun 2026, standardized by Business Quant from the company’s SEC filings.

Cash Flow Statement Mar2020 Jun2020 Sep2020 Dec2020 Mar2021 Jun2021 Sep2021 Dec2021 Mar2022 Jun2022 Sep2022 Dec2022 Mar2023 Jun2023 Sep2023 Dec2023 Mar2024 Jun2024 Sep2024 Dec2024 Mar2025 Jun2025 Sep2025 Dec2025 Mar2026 Jun2026
Operating Activities
Net Income
-3.37M-3.22M-3.40M-3.87M-3.55M-4.09M-4.46M-3.50M-4.25M-4.18M-3.94M-4.11M-3.14M-4.17M-4.57M-4.46M-2.65M-8.16M-2.16M-1.81M
Depreciation and DepletionDep. & Depletion
442.00535.00534.00534.00392.00321.00321.00322.00321.00320.00735.00
Share-based CompensationStock Comp.
0.80M0.67M0.83M0.90M0.58M0.64M0.73M0.73M0.76M0.75M0.77M0.78M0.44M0.30M0.24M0.18M0.15M0.23M-0.06M
Asset Writedowns and ImpairmentWritedown
Cash from OperationsCash from Ops.
-5.63M-3.54M-3.12M-3.15M-4.60M-2.21M-4.96M-2.11M-3.73M-2.60M-3.94M-2.48M-2.51M-3.40M-5.05M-4.02M-2.57M-7.01M-1.93M
Depreciation, Depletion & Amortization
Depreciation & Amortization (CF)Dep. & Amort.
442.00535.00534.00534.00392.00321.00321.00322.00321.00320.00735.00
Change in Working Capital
Change in Accured ExpensesChange Accured Exp.
-2.79M-1.27M-0.93M-0.06M-0.74M0.57M-1.63M0.28M0.26M0.41M-1.24M
Other Working Capital ChangesOther WC Changes
2.00M-0.29M-0.36M-0.48M1.58M-0.02M-0.32M1.67M-0.26M-0.41M1.24M-0.39M-0.17M-1.15M-0.01M-0.81M1.91M-0.12M-0.25M
Investing Activities
Capital ExpendituresCapex
0.00M
Sales of Property, Plant and EquipmentPP&E (Sale)
0.17M
Cash from Investing ActivitiesCash from Investing
-0.00M0.45M-2.80M-15.81M-2.94M5.12M2.14M8.00M7.00M
Financing Activities
Cash from Financing ActivitiesCash from Financing
42.52M0.36M0.32M0.04M2.59M1.80M3.15M6.28M2.24M
Debt Issuance and Repayment
Current Debt
0.37M
Change in Capital Stock
Net Equity Issued and RepurchasedNet Equity Issued
-0.93M0.34M0.34M0.04M3.00M2.14M3.48M0.58M2.34M-4.15M
Additional items
Exchange Rate EffectFX Effect
Change in Cash
36.89M-2.73M-5.92M-18.96M-7.54M2.91M-2.82M5.89M3.27M-2.60M-3.62M-2.44M0.08M-1.59M-1.90M2.27M-0.33M-7.01M6.06M
Free Cash FlowFCF
-5.63M-3.54M-3.12M-3.15M-4.60M-2.21M-4.96M-2.11M-3.73M-2.60M-3.94M-2.48M-2.51M-3.40M-5.05M-4.02M-2.57M-7.01M-1.93M
Net Cash FlowNCF
36.89M-2.73M-5.92M-18.96M-7.54M2.91M-2.82M5.89M3.27M-2.60M-3.62M-2.44M0.08M-1.59M-1.90M2.27M-0.33M-7.01M-1.93M

Indaptus Therapeutics Cash Flow Statement API

Pull Indaptus Therapeutics's standardized financial statements into your own models, spreadsheets and apps with the Business Quant Financial Statements API. The request below follows the statement, frequency and period selected above. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/statements?ticker=INDP&statement=CF&frequency=Quarter&period=all&api_key=YOUR_API_KEY